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Photochemical formation of quinone methides
from peptides containing modiﬁed tyrosine†
Antonija Husak,a Benjamin P. Noichl,b Tatjana Šumanovac Ramljak,a
Margareta Sohora,a Đani Škalamera,a Nediljko Budišab and Nikola Basarić*a
We have demonstrated that quinone methide (QM) precursors can be introduced in the peptide structure
and used as photoswitchable units for peptide modiﬁcations. QM precursor 1 was prepared from pro-
tected tyrosine in the Mannich reaction, and further used as a building block in peptide synthesis.
Moreover, peptides containing tyrosine can be transformed into a photoactivable QM precursor by the
Mannich reaction which can aﬀord monosubstituted derivatives 2 or bis-substituted derivatives 3.
Photochemical reactivity of modiﬁed tyrosine 1 and dipeptides 2 and 3 was studied by preparative
irradiation in CH3OH where photodeamination and photomethanolysis occur. QM precursors incorpor-
ated in peptides undergo photomethanolysis with quantum eﬃciency ΦR = 0.1–0.2, wherein the peptide
backbone does not aﬀect their photochemical reactivity. QMs formed from dipeptides were detected by
laser ﬂash photolysis (λmax ≈ 400 nm, τ = 100 μs–20 ms) and their reactivity with nucleophiles was
studied. Consequently, QM precursors derived from tyrosine can be a part of the peptide backbone which
can be transformed into QMs upon electronic excitation, leading to the reactions of peptides with
diﬀerent reagents. This proof of principle showing the ability to photochemically trigger peptide modiﬁ-
cations and interactions with other molecules can have numerous applications in organic synthesis,
materials science, biology and medicine.
Introduction
Quinone methides (QMs) are reactive intermediates in the
chemistry and photochemistry of phenols that have received
significant scientific attention over the past twenty years.1,2
Interest in their chemistry has been initiated due to their
applications in synthesis,3,4 as well as their biological
activity.5–7 To date, the biological eﬀects of QMs have been
connected to their reactivity with nucleobases8–10 and
DNA.11–14 More importantly, some antineoplastic antibiotics
base their action on the metabolic formation of QMs that
cross-link DNA.15,16 A significant endeavor in elucidating the
reactivity of QMs with DNA has been undertaken by Rokita
et al.,1,16 who demonstrated reversible alkylation of DNA by
QMs.9 They have shown that QMs act as “immortal” species
that are capable of forming thermodynamically most stable
DNA cross-adducts.17–19 However, it has also been demon-
strated that QMs react with amino acids20,21 and proteins.22
Thus, we have recently shown that the antiproliferative activity
of QMs formed in the phototautomerization of hydroxy-
phenylanthracenes is due to the reaction with intracellular pro-
teins, rather than with DNA.23
Formation of QMs often requires harsh conditions such as
elevated temperature,24,25 or the use of biologically inaccept-
able oxidants26 or F−.13 On the contrary, photochemical reac-
tions require mild conditions which allow for the generation
of QMs in living cells.7,27 Two main photochemical reactions
for the formation of QMs are dehydration of hydroxymethyl
substituted phenols28,29 and deamination of aminomethyl30 or
ammoniummethylphenols.21,31 Photodeamination can also be
initiated by an intramolecular photoinduced electron transfer
reaction with naphthalene diimide as a photooxidizing
agent.32 Freccero et al. have used photodeamination of
Mannich salts for the investigation of biological activity of
QMs,33,34 and the ability of QM derivatives to selectively target
guanine quadruplexes has been demonstrated.35–37 We have
investigated the dependence of the photodeamination
eﬃciency on pH in aqueous media and have shown that this
reaction is the most eﬃcient one for zwitterionic prototropic
forms at 8.5 < pH < 11.1.38 Furthermore, Freccero et al.
focused their study on the structure of QM precursors resulting
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in high eﬃciency of deamination or high intersystem crossing
yields and population of triplets.39
Herein we report the synthesis and photochemical reactivity
of Mannich derivatives of tyrosine 1, dipeptide derivatives Phe-
Tyr 2 and 3. Photochemical reactivity was investigated by per-
forming preparative irradiation in CH3OH as a nucleophilic
solvent where photomethanolysis takes place, whereas QMs
were detected by laser flash photolysis (LFP). Furthermore, we
have prepared a tripeptide containing 1 and incorporated it in
a 20-residue mini-protein, the Trp-Cage analogue TC10b.40 It
is a synthetic mini-protein, derived from exendin-4,41 with a
known and defined secondary structure, widely used to study
folding dynamics and their pathways.41,42 Recently, the TC5b
analogue was used for the incorporation of non-canonical fluo-
rescent amino acids into the core of the tryptophan cage
forming motif (Trp6 and Pro17–19)43 and from the development
of this system, TC10b was found to be a more suitable ana-
logue of Trp-Cage for the current experiments reported here,
showing that the QM precursor can be imbedded into proteins
whilst retaining its photochemical reactivity. QMs formed in
the photochemical reactions initiate alkylation of proteins.
Therefore, incorporation of the photoswitchable units in pro-
teins can have numerous applications in organic synthesis,
materials science, biology and medicine.
Results and discussion
Synthesis
QM precursor, a derivative of tyrosine 1B was synthesized in
the Mannich reaction from BOC-Tyr-OBn and Eschenmoser’s
salt (Scheme 1), according to the procedure in the literature
precedent.38 BOC-Tyr-OBn was prepared according to the usual
procedures for the introduction of protective groups.44
Unnatural amino acid 1B was deprotected at the N-site by the
use of trifluoroacetic acid (TFA) to yield 1C, or at the
C-terminus by hydrogenolysis to furnish 1A. Both deprotec-
tions were conducted in high yields without any interference
or change of the aminomethylphenol moiety.
The synthesis of dipeptides with the incorporated QM pre-
cursor was conducted in two ways, by introduction of the func-
tional group in the Mannich reaction after peptide coupling,
or by the use of the QM precursor in the peptide coupling
(Scheme 2).
Dipeptide BOC-Phe-Tyr-OH was synthesized from BOC-Phe-
OH by the use of N-hydroxysuccinimide (NHS) and 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide (EDC) activation.45
Protected dipeptide BOC-Phe-Tyr-OBn was transformed into
QM precursor dipeptide 2B in the Mannich reaction with
Eschenmoser’s salt where only one aminomethyl group was
introduced. Preparation of the Mannich reagent in situ with an
excess of dimethylamine and formaldehyde allowed for the
introduction of two aminomethyl groups, yielding 3B. Thus,
we have demonstrated that tyrosine in a peptide can be trans-
formed into a QM precursor in the Mannich reaction.
However, peptides cannot contain amino acids that react with
electrophiles (e.g. tryptophan).
The other synthetic protocol for the preparation of peptide
2B was the coupling of activated BOC-Phe-OH with the N-free
site of QM precursor 1C (Scheme 2). Peptide coupling by the
use of NHS and EDC activation45 was conducted, giving the
desired QM precursor in a moderate yield (57%).
Scheme 1
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Consequently, we have demonstrated that QM precursor 1C
can be used as a building block in peptide synthesis. Attempts
to perform activation of the carboxylic group in 1A and couple
it with H-Phe-OBn failed by the use of NHS and EDC acti-
vation47 or by the N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-
yl)uronium hexafluorophosphate (HBTU) and 1-hydroxybenzo-
triazole (HOBT) activation protocol.46 Nevertheless, dipeptides
2 and 3 can be easily deprotected, and in principle, used in
further synthesis of more complex molecules.
The synthesis of more complex peptides with incorporated
modified tyrosine was accomplished by a combination of solid
and liquid phase peptide synthesis (LPPS & SPPS). Tripeptide 4
was synthesized via LPPS deploying the alternating activation
of the C-terminus (EDC·HCl and NHS, Scheme 3) and coupling
of the unprotected amino acids Ala-OH and 1 (Scheme 3). For
the latter coupling step, the required deprotection of 1B was
accomplished in two steps, using H2/Pd in EtOH for the selec-
tive removal of the benzyl group, followed by 4 M HCl in
dioxane to yield the desired unprotected amino acid 1 (97%,
two steps), which was used for the coupling. This approach
provides the desired amino acid sequence – Asp–Ala–1– (4) –
in a completely protected manner, suitable for the synthesis of
longer peptide chains.
The synthesis of the corresponding mini-protein was
accomplished using SPPS. Therefore, the previously syn-
thesized intermediate 5 on the solid support (see Scheme S1
in the ESI†) and protected tripeptide 4 were utilized. For the
intermediate 5 we have chosen the first 17 amino acids of the
Trp-Cage analogue TC10b.40 In this way the TC10b analogue
was obtained, bearing 1 instead of tyrosine at the position
Scheme 2
Scheme 3
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3. The coupling was performed in the presence of O-(benzo-
triazol-1-yl)-N,N,N′,N′-tetramethyluronium tetrafluoroborate
(TBTU) and N,N-diisopropylamine (DIPEA) for 1 hour in N,N-
dimethylformamide (DMF), followed by an acid deprotection
step, yielding the desired peptide TC10b_3Y1 (Scheme 4). The
structure of the peptide was confirmed by MS (ESI-HR: m/z =
1072.53394, calculated for [M + H]+: 1072.53366; Δm/z =
0.2 ppm).
Photophysical properties
The spectral properties of QM precursors 1 are anticipated not
to diﬀer from those of the parent molecule. However, it is
interesting to investigate the spectral properties of dipeptides
2 and 3 that contain two chromophores, phenylalanine, and
the modified tyrosine. Their spectral and photophysical pro-
perties were investigated in CH3CN (Table 1, for spectra see
Fig. S2–S7 in the ESI†).
In the absorption spectra of dipeptides 2 and 3A (Fig. S2
and S5 in the ESI†) the typical absorption band at ≈280 nm
was observed corresponding to the S0 → S1 absorption of the
tyrosine moiety. In the emission spectra recorded in CH3CN
(Fig. S3 and S6 in the ESI†), the typical dual fluorescence was
observed with one main band at 305–315 nm, and a shoulder
at 370 nm for 2, and 430 nm for 3A. This dual fluorescence is
due to the emission of phenol and phenolate. Both species are
present in equilibrium in S0, but the phenolate is also formed
in S1 by excited state intramolecular proton transfer (ESIPT), as
seen for the Mannich derivatives of cresol.38 Namely, upon
electronic excitation, phenols exhibit enhanced acidity (un-
substituted phenol pK*a ¼ 3:6),48,49 and the methylamine
group has a role of a basic site. The appearance of the emission
spectra depends on the excitation and emission wavelength,
which is expected in a bichromophoric system containing Phe
and Tyr. Moreover, due to the acidic and basic functionalities
in the molecule, the dipeptides exhibit several prototropic
forms. Therefore, fluorescence quantum yield depends on the
excitation wavelength, and the decay of fluorescence cannot be
fit to single exponential function. Due to the complexity of the
chromophoric system, no attempt was made to assign the fluo-
rescence decay components. In Table 1, only an estimate for
the fluorescence quantum yield (ΦF) is reported, measured by
the use of anisole in cyclohexane (ΦF = 0.29).
47 Generally,
ΦF values are very low, probably due to the relatively eﬃcient
deactivation from S1 by photodeamination giving QMs.
38
Addition of H2O to the CH3CN solution until a concentration
of 4 M was reached quenched the fluorescence to about 2–3
times, but further additions did not result in additional
quenching. Due to very weak fluorescence in the aqueous solu-
tion and complexity due to several pH-dependant prototropic
forms,38 we constrained our measurements to CH3CN solution
only.
Photochemistry
Photodeamination of aminomethylphenols in aqueous
CH3OH leads to photomethanolysis products via QM inter-
mediates.32,38,50 To demonstrate that photomethanolysis of
modified tyrosine 1 and dipeptides 2 and 3 also takes place,
we performed preparative irradiation of 1B, 2B and 3B. Fully
protected compounds (bearing BOC and Bn) were chosen for
preparative irradiation to make the product isolation easier.
The irradiation experiments were conducted by irradiating
CH3OH solutions at 300 nm and by analyzing the composition
Scheme 4
Table 1 Spectral and photophysical properties of dipeptides in CH3CN
λabs/nm (ε/dm
3 mol−1 cm−1)a λem
b/nm ΦF
c τ d/ns
2 282 (500) 305 ≈0.006 0.28 ± 0.05 (0.32)
0.71 ± 0.06 (0.44)
5.0 ± 0.1 (0.24)
3A 286 (1700) 315 ≈0.007 0.22 ± 0.04 (0.26)
0.75 ± 0.03 (0.54)
6.0 ± 0.1 (0.12)
aMaximum in the absorption spectrum and molar absorption coeﬃcient in the brackets. bMaximum in the emission spectrum. c Approximate
quantum yield of fluorescence measured by the use of anisole in cyclohexane (ΦF = 0.29)
47 as a reference upon excitation at 260 nm. dDecay of
fluorescence at 310 nm measured by time-correlated single photon counting (SPC), pre-exponential factors are given in brackets.
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of the solutions by HPLC. After the irradiation, the photo-
products were isolated by preparative TLC and characterized
by NMR spectroscopy. Methanolysis of 1B until the conversion
of 44% gave methyl ether 6, with the isolated yield of 28%
(eqn (1)).
ð1Þ
Similarly, irradiation of dipeptide 2B until the conversion
of 63% was achieved gave cleanly only methyl ether 7 (isolated
yield 21%, eqn (2)).
ð2Þ
On the other hand, irradiation of 3B gave a mixture of pro-
ducts 8 and 9 whose ratio depended on the irradiation time
(eqn (3)). Thus, after irradiating for 30 min, the ratio of 8 : 9
was 1 : 1. After prolonged irradiation until the conversion of
68%, 9 was isolated in 21% yield. Similarly, after irradiation of
peptide 3A until the conversion of 40% dimethoxy product 10
was isolated in 5% yield (eqn (4)).
ð4Þ
The eﬃciency of the photomethanolysis reaction (ΦR) was
measured by the use of a primary actinometer, KI/KIO3 Φ254 =
0.74),47,51 and a secondary actinometer, photomethanolysis of
2-hydroxymethylphenol (Φ254 = 0.23).
28 The values are com-
piled in Table 2. The eﬃciency was measured for all Mannich
derivatives 1 to demonstrate that the protective groups on tyro-
sine do not aﬀect the photomethanolysis reaction. The corres-
ponding photoproducts from 1, 1A and 1C were detected by
HPLC, but product isolation was conducted only for the fully
protected isomer 1B. Moreover, the ΦR was measured for the
dipeptide bearing one or two aminomethyl groups.
The values in Table 2 indicate similar photochemical reac-
tion eﬃciencies of tyrosine QM precursors 1A–1C, irrespective
of the protective groups used. Moreover, QM precursors
remain photochemically reactive in dipeptides 2B and 2C
where photomethanolysis takes place with similar eﬃciencies
to those of derivatives 1. Dipeptides 2 contain two chromo-
phores, Phe and Tyr both of which can be excited at 254 nm.
Similar photomethanolysis eﬃciency for 2 suggests that
energy transfer from Phe to Tyr takes place leading to photo-
elimination, regardless of which chromophore was initially
excited.
Photochemical reactivity was also tested with the protected
tripeptide 4 in the presence of benzyl mercaptan. After the
irradiation of the reaction solution for 20 min at 254 nm, the
completely oxidized product was detected with the conversion
of 23%. Only a minor fraction of the products of photoreaction
was identified to be the non-oxidized product (see the ESI†).
These results indicate that tripeptide also undergoes photo-
deamination giving QMs that can be trapped with nucleo-
philes. Irradiation of the mini-protein TC10b_3Y1 was per-
formed in CH3OD where the photomethanolysis reaction is
anticipated. After one hour irradiation at 254 nm, MS analysis
indicated its conversion to the corresponding methyl ether,
ð3Þ
Table 2 Quantum yields of photomethanolysis (ΦR)
a
ΦR
1A 0.17 ± 0.03
1B 0.17 ± 0.04
1C·TFA 0.23 ± 0.04
2B 0.28 ± 0.04
2C 0.32 ± 0.05
3A 0.07 ± 0.02
a Irradiation experiments were performed in CH3OH at 254 nm.
Measurement was performed in duplicate by the use of two actin-
ometers, KI/KIO3 (Φ254 = 0.74)
47,51 and 2-hydroxymethylphenol (Φ254 =
0.23).28
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which clearly demonstrates that photoreaction of the QM pre-
cursor is feasible, and shows this reaction’s applicability to
protein systems.
Laser flash photolysis (LFP)
To detect QM intermediates in the photochemistry of dipep-
tides 2 and 3, LFP was used. The samples were excited with a
Nd:YAG laser at 266 nm. The measurements were performed
in N2 and O2-purged CH3CN solution, where O2 is expected to
quench triplets and radicals, but not QMs. Moreover, the
spectra and decay kinetics were measured in CH3CN and
CH3CN–H2O (1 : 1) where the diﬀerence is expected due to
ESPT pathways,52–55 and diﬀerent reactivities of QMs in aprotic
and protic solution (for the transient absorption spectra see
Fig. S8–S16 in the ESI†).38,56–60
Dipeptide 2 is not well soluble in CH3CN. However, in neat
CH3CN solution a transient was detected with a maximum at
390 nm (Fig. S8 in the ESI†), tentatively assigned to 2-QM
based on the comparison with the previously published
spectra of o-QM derivatives.38,61 Due to a long lifetime of the
transient and its low intensity, decay kinetics in CH3CN was
not investigated. Spectra of better quality were obtained in
CH3CN–H2O (1 : 1) solution where the compound is more
soluble (Fig. 1). The transient assigned to 2-QM was detected
with a maximum at 400 nm. It was formed within a laser pulse
and it decayed to the baseline with unimolecular kinetics and
lifetime of 20 ± 2 ms (Table 3). To verify its assignment a
quenching study was performed with ethanolamine (EtAm)
and NaN3, ubiquitous QM quenchers,
38,60,62–66 as well as with
ethyl vinyl ether (EVE) that reacts with QMs in the Diels–Alder
reaction (Fig. S10–S12 in the ESI†).67 The measured quenching
constants (Table 3) are in agreement with the expected reactiv-
ity of QM with nucleophiles.38
In the CH3CN solution of 3A, a transient was detected with a
maximum at 400 nm (Fig. S9 and S13 in the ESI†). The transi-
ent was formed within the laser pulse and decayed to the base-
line with unimolecular kinetics and a lifetime of 110 ± 10 μs.
The transient was not aﬀected with O2, but it was quenched
with EtAm (Table 3), so it was assigned to 3A-QM. The same
transient corresponding to 3A-QM was also detected in
aqueous solution (Fig. S14†), but its decay was slower (τ =
13 ms). Although this finding seemed counterintuitive at first,
the same behavior was observed with bifunctional cresol
derivatives.38 Most probably, the carboxylic acid from the
C-terminus of the peptide in CH3CN acts as an acidic catalyst,
shortening the QM lifetime, whereas in aqueous solution at
pH 7, this carboxylic acid is deprotonated. Quenching of the
transient in aqueous solution was performed with EtAm and
EVE, revealing the typical reactivity of QM and proving that the
transient assignment was correct.
Conclusions
We synthesized new QM precursors, tyrosine derivatives 1, and
incorporated them in the dipeptides 2. Moreover, we have
demonstrated that QM precursors can be made from peptides
containing tyrosine in the Mannich reaction, or by using modi-
fied tyrosine 1 as a building block in the usual peptide syn-
thesis. Although peptide derivatives have several acidic and
Fig. 1 Transient absorption spectra of O2-purged CH3CN–H2O (1 : 1)
solution of 2. Inset: decay of transient absorbance at 400 nm.
Table 3 Data obtained by LFP for 2 and 3A
Transient τCH3CN
a/ms τCH3CN–H2O
b/ms kq (EtAm)
c/M−1 s−1 kq (NaN3)
d/M−1 s−1 kq (EVE)
e/M−1 s−1
2-QM — 20 ± 2 2.3 × 105 1.1 × 107 9.9 × 102
3A-QM 0.11 ± 0.01 13 ± 3 2.3 × 105 f 9.9 × 104 — 5.8 × 103
a Lifetime in O2-purged CH3CN solution.
b Lifetime in O2-purged CH3CN–H2O solution.
cQuenching rate constant with ethanolamine (EtAm),
measured in CH3CN–H2O.
dQuenching rate constant with NaN3, measured in CH3CN–H2O.
eQuenching rate constant with ethyl vinyl ether
(EVE), measured in CH3CN–H2O.
fMeasured in CH3CN.
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basic sites, and their photophysical properties are complex,
photochemical reactivity of modified tyrosine and dipeptides
in the deamination reaction is not aﬀected by the peptide
backbone. Moreover, reactivity of QM-dipeptides that are
formed in the photodeamination reactions is not altered by
the peptide. Consequently, photochemical reactions of 2, 3
and TC10b_3Y1 show a proof of principle that the QM precur-
sor can be introduced into the peptide and used as a photo-
chemical switch to enable the interaction and alkylation of
peptides with other molecules of interest, which can have a tre-
mendous impact in chemistry and biology.
Experimental
General
1H and 13C NMR spectra were recorded at 300, 500 or 600 MHz
at rt, using TMS as a reference and chemical shifts were
reported in ppm. Melting points were determined using
Mikroheiztisch apparatus and were not corrected. HRMS were
obtained on a MALDI TOF/TOF instrument. ESI-MS were
obtained on a LTQ Orbitrap instrument. Irradiation experi-
ments were performed in a reactor equipped with 11 lamps
with the output at 300 nm or a reactor equipped with 8 lamps
at 254 or 300 nm (1 lamp 8 W). During irradiation, the ir-
radiated solutions were continuously purged with argon and
cooled by a tap-water finger-condenser. Solvents for irradiation
were of HPLC purity. Chemicals were purchased from the
usual commercial sources and were used as received. Solvents
for chromatographic separations were used as they were deli-
vered by the supplier (p.a. or HPLC grade) or purified by distil-
lation (CH2Cl2). Preparations of the known compounds,
L-BOC-Tyr(OH)-OH,68 L-BOC-Tyr(OH)-OBn,44 L-BOC-Phe-OSu,45
and L-BOC-Phe-Tyr(OH)-OH,69,70 are given in the ESI.†
BOC-Tyr[CH2N(CH3)2]-OBn (1B)
A flask was charged with BOC-Tyr-OBn (1.11 g, 3.0 mmol) and
CH2Cl2 (150 mL) was added. To this solution, K2CO3 (0.21 g,
1.5 mmol) and Eschenmoser’s salt (0.28 g, 3.0 mmol) were
added and the reaction mixture was stirred at rt for 5 days.
When the reaction was completed, 0.5 M HCl (100 mL) was
added, and the product was extracted with ethyl acetate
(3 × 100 mL). The solvent was removed on a rotary evaporator
to aﬀord an oily product. The product was purified by column
chromatography on aluminium oxide (II–III) using 0 → 5%
CH3OH in CH2Cl2 as the eluent to aﬀord the pure product
(0.72 g, 56%) in the form of colorless crystals.
Colorless crystals, mp 85–87 °C; 1H NMR (CD3OD,
300 MHz) δ/ppm: 7.35–7.22 (m, 5H), 6.91 (dd, J = 1.6, 8.0 Hz,
1H), 6.84 (d, J = 1.6 Hz, 1H), 6.64 (d, J = 8.0 Hz, 1H), 5.12 (d, J =
12.0 Hz, 1H), 5.06 (d, J = 12.0 Hz, 1H), 4.37–4.23 (m, 1H), 3.53
(s, 2H), 2.96 (dd, J = 6.4, 13.6 Hz, 1H), 2.84 (dd, J = 8.0, 13.6
Hz, 1H), 2.26 (s, 6H), 1.38 (s, 9H); 13C NMR (CD3OD, 75 MHz)
δ/ppm: 173.7 (s, 1C), 157.8 (s, 1C), 157.7 (s, 1C), 137.1 (s, 1C),
131.1 (d, 2C), 130.5 (d, 3C), 129.5 (d, 1C), 129.3 (d, 1C), 128.6
(s, 1C), 123.5 (s, 1C), 116.6 (d, 1C), 80.6 (s, 1C), 67.8 (t, 1C),
62.4 (t, 1C), 56.9 (d, 1C), 44.7 (q, 2C), 37.9 (t, 1C), 28.6 (q, 3C);
HRMS (MALDI-TOF) m/z [M + H]+ calcd for C24H32N2O5
429.2389, found 429.2368.
BOC-Tyr[CH2N(CH3)2]-OH (1A)
In a vessel for hydrogenation BOC-Tyr[CH2N(CH3)2]-OBn (1B)
(390 mg, 0.9 mmol) was dissolved in anhydrous EtOH (40 mL),
and 10% Pd/C (200 mg) was added. The hydrogenation was
carried out for 5 h at the pressure of 63 psi. The crude reaction
mixture was filtered and the solvent was evaporated on a rotary
evaporator. The residue was purified by column chromato-
graphy on silica gel using 20 → 100% CH3OH in CH2Cl2 to
aﬀord the pure product (274 mg, 89%) in the form of a color-
less solid.
Colorless solid, mp 133–135 °C; 1H NMR (CD3OD,
300 MHz) δ/ppm: 7.10 (s, 1H), 7.09 (d, J = 8.0 Hz, 1H), 6.79 (d,
J = 8.0 Hz, 1H), 4.16 (s, 2H), 3.34 (s, 2H), 3.03 (dd, J = 5.0, 13.5
Hz, 1H), 2.88 (dd, J = 6.5, 13.5 Hz, 1H), 2.77 (s, 6H), 1.39 (s,
9H); 13C NMR (CD3OD, 75 MHz) δ/ppm: 178.3 (s, 1C), 157.2 (s,
1C), 156.4 (s, 1C), 134.1 (d, 1C), 133.8 (d, 1C), 130.9 (s, 1C),
117.7 (s, 1C), 116.1 (d, 1C), 80.0 (s, 1C), 58.4 (t, 1C), 58.3 (d,
1C), 43.3 (q, 2C), 38.9 (t, 1C), 28.8 (q, 3C); HRMS (MALDI-TOF)
m/z [M + H]+ calcd for C17H26N2O5 339.1920, found 339.1911.
TFA·H-Tyr[CH2N(CH3)2·TFA]-OBn (1C)
BOC-Tyr[CH2N(CH3)2]-OBn (1B) (335 mg, 0.8 mmol) was dis-
solved in CH2Cl2 (3 mL). TFA/CH2Cl2 (1 : 1, 4 mL) was added
and the reaction mixture was stirred at rt for 2 h. The solvent
was removed by distillation in a vacuum to aﬀord an oily
product quantitatively.
Colorless oil; 1H NMR (CD3OD, 300 MHz) δ/ppm: 7.41–7.28
(m, 5H), 7.14–7.09 (m, 2H), 6.86 (d, J = 8.8 Hz, 1H), 5.26 (d, J =
11.5 Hz, 1H), 5.20 (d, J = 11.5 Hz, 1H), 4.31 (dd(t), J = 7.0 Hz),
4.22 (d, J = 12.9 Hz, 1H), 4.13 (d, J = 12.9 Hz, 1H), 3.15 (d, J =
7.5 Hz, 2H), 2.79 (d, J = 7.5 Hz, 6H); 13C NMR (CD3OD,
75 MHz) δ/ppm: 169.9 (s, 1C), 157.5 (s, 1C), 136.2 (s, 1C), 134.4
(d, 1C), 134.0 (d, 1C), 129.9 (d, 1C), 129.8 (d, 2C), 129.7 (d, 2C),
126.6 (s, 1C), 118.0 (s, 1C), 117.0 (d, 1C), 69.3 (t, 1C), 58.2
(t, 1C), 55.2 (d, 1C), 43.2 (q, 2C), 36.5 (t, 1C); HRMS
(MALDI-TOF) m/z [M]+ calcd for (C23H26F6N2O7) 556.1644,
found 556.1635.
BOC-Phe-Tyr[CH2N(CH3)2]-OBn (2B)
A flask was charged with TFA·H-Tyr[CH2N(CH3)2·TFA]-OBn
(1C) (594 mg, 1.8 mmol), NaHCO3 (605 mg, 7.2 mmol) and
THF–H2O (1 : 1, 24 mL). To the mixture, a solution of succi-
nimide-activated phenylalanine (732 mg, 2.0 mmol) in THF
(14 mL) was added dropwise, and the reaction mixture was
stirred at rt for 2 days. THF was removed on a rotary evapor-
ator, and the reaction mixture was acidified with 0.5 M HCl to
pH 2, and the product was extracted with ethyl acetate
(3 × 30 mL). The organic layer was washed with water and
dried over anhydrous Na2SO4. After filtration and evaporation
of the solvent, the product was purified by column chromato-
graphy on silica gel using 0 → 5% CH3OH in CH2Cl2 as the
Paper Organic & Biomolecular Chemistry
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eluent to aﬀord the pure product (749 mg, 57%) in a form of a
colorless solid.
Colorless solid; mp 92–94 °C; 1H NMR (CD3OD, 300 MHz)
δ/ppm: 7.37–7.27 (m, 5H), 7.25–7.15 (m, 5H), 7.11 (s, 1H), 7.08
(d, J = 8.1 Hz, 1H), 6.78 (d, J = 8.1 Hz, 1H), 5.12 (s, 2H), 4.68
(ddd(t), J = 7.0 Hz, 1H), 4.30–4.22 (m, 1H), 4.13 (s, 2H), 3.09
(dd, J = 6.0, 14.0 Hz, 1H), 3.02–2.89 (m, 2H), 2.75 (s, 6H),
2.75–2.65 (m, 1H), 1.34 (s, 9H); 13C NMR (CD3OD, 75 MHz)
δ/ppm: 174.3 (s, 1C), 172.3 (s, 1C), 157.5 (s, 1C), 156.7 (s, 1C),
138.5 (s, 1C), 137.0 (s, 1C), 134.1 (d), 133.9 (d), 134.0 (d), 133.0
(d), 129.6 (d), 129.5 (d), 129.4 (d), 129.4 (s), 129.3 (d), 129.2 (d),
127.7 (d), 127.5 (d), 118.2 (s, 1C), 116.4 (d, 1C), 80.6 (s, 1C),
68.0 (t, 1C), 58.3 (t, 1C), 57.1 (d, 1C), 55.3 (d, 1C), 43.2 (q, 2C),
39.3 (t, 1C), 37.1 (t, 1C), 28.6 (q, 3C); HRMS (MALDI-TOF) m/z
[M + H]+ calcd for C33H41N3O6 576.3074, found 576.3087.
BOC-Phe-Tyr[CH2N(CH3)2]-OBn (2B)
A flask was charged with BOC-Phe-Tyr-OBn (146 mg,
0.28 mmol) dissolved in CH2Cl2 (20 mL). To the reaction
mixture, K2CO3 (20 mg, 0.14 mmol) and Eschenmoser’s salt
(26 mg, 0.28 mmol) were added and the reaction was stirred at
rt for 5 days. When the reaction was completed, 0.3 M HCl
(50 mL) was added, and the product was extracted with ethyl
acetate (3 × 50 mL). The solvent was removed on a rotary evap-
orator to aﬀord an oily substance which was purified by
column chromatography on silica gel using 5 → 10% CH3OH
in CH2Cl2 as the eluent to aﬀord the pure product (50 mg,
31%) in a form of a colorless solid.
BOC-Phe-Tyr[CH2N(CH3)2]-OH (2A)
In a vessel for hydrogenation BOC-Phe-Tyr[CH2N(CH3)2]-OBn
(2B) (263 mg, 0.4 mmol) was dissolved in anhydrous EtOH
(30 mL), and 10% Pd/C (100 mg) was added. Hydrogenation
was carried out for 6 h at the pressure of 63 psi. The crude
reaction mixture was filtered and the solvent was removed on a
rotary evaporator to aﬀord the pure product (221 mg, 99%).
Yellowish oil; 1H NMR (CD3OD, 300 MHz) δ/ppm: 7.29–7.13
(m, 7H), 6.84 (d, J = 8.0 Hz, 1H), 4.63–4.56 (m, 1H), 4.32–4.18
(m, 3H), 3.15 (dd, J = 5.0, 14.0 Hz, 1H), 3.04 (dd, J = 5.0, 14.0
Hz, 1H), 2.99–2.88 (m, 1H), 2.83 (s, 6H), 2.78–2.69 (m, 1H),
1.35 (s, 9H); 13C NMR (CD3OD, 150 MHz) δ/ppm: 174.6 (s, 1C),
174.0 (s, 1C), 157.6 (s, 1C), 156.5 (s, 1C), 138.6 (s, 1C), 134.3
(d, 1C), 134.1 (d, 1C), 130.3 (d, 2C), 130.0 (s, 1C), 129.4 (d, 2C),
127.7 (d, 1C), 117.4 (s, 1C), 116.4 (d, 1C), 80.7 (s, 1C), 58.3
(t, 1C), 57.4 (d, 1C), 55.5 (d, 1C), 43.3 (q, 2C), 39.2 (t, 1C), 37.8
(t, 1C), 28.7 (q, 3C), one singlet was not seen; HRMS
(MALDI-TOF) m/z [M + H]+ calcd for C26H35N3O6 486.2604,
found 486.2627.
BOC-Phe-Tyr[CH2N(CH3)2]2-OH (3A)
To a solution of BOC-Phe-Tyr-OH (200 mg, 0.5 mmol) in 40%
aqueous dimethylamine (1 mL, 7.8 mmol), formalin (37% aq,
0.5 mL, 6.4 mmol) was added dropwise and the temperature
was maintained below 30 °C (overall time was 30 min). The
reaction mixture was stirred at rt for 1 h, and then at the temp-
erature of 90–95 °C for 2 h. Then, sodium chloride was added
and stirring was continued for 20 min. The resulting oil was
subjected to column chromatography on aluminum oxide (act.
V) using 5→ 10% CH3OH in CH2Cl2 as the eluent to aﬀord the
pure product (21 mg, 8%) in the form of a colorless solid.
Colorless solid; mp 124–126 °C; 1H NMR (CD3OD,
300 MHz) δ/ppm: 7.30–7.15 (m, 5H), 7.04 (s, 2H), 4.39 (ddd(t),
J = 5.0 Hz, 1H), 4.27–4.19 (m, 1H), 4.00 (d, J = 13.6 Hz, 2H),
3.95 (d, J = 13.6 Hz, 2H), 3.15–2.95 (m, 3H), 2.80–2.65 (m, 1H),
2.59 (s, 12H), 1.35 (s, 9H); 13C NMR (CD3OD, 150 MHz) δ/ppm:
177.2 (s, 1C), 173.3 (s, 1C), 158.6 (s, 1C), 157.5 (s, 1C), 138.8 (s,
1C), 133.3 (d, 1C), 130.3 (d, 2C), 129.8 (s, 1C), 129.4 (d, 2C),
127.7 (d, 2C), 120.2 (s, 2C), 80.4 (s, 1C), 60.4 (t, 2C), 57.7 (d,
1C), 57.4 (d, 1C), 43.8 (q, 4C), 39.3 (t, 1C), 38.2 (t, 1C), 28.7 (q,
3C); HRMS (MALDI-TOF) m/z [M + H]+ calcd for C29H42N4O6
543.3183, found 543.3177.
BOC-Phe-Tyr[CH2N(CH3)2]2-OBn (3B)
Prepared from BOC-Phe-Tyr-OBn (500 mg, 1.0 mmol), di-
methylamine (40% aq, 2 mL, 3.0 mmol), and formalin (37%
aq, 1 mL, 2.5 mmol), according to the procedure for 3A. The
reaction after purification aﬀorded the product (68 mg, 11%)
in the form of colorless oil.
Colorless oil; 1H NMR (CD3OD, 600 MHz) δ/ppm: 7.36–7.27
(m, 5H), 7.25–7.21 (m, 2H), 7.20–7.15 (m, 3H), 6.87 (s, 2H),
5.10 (s, 2H), 4.68 (ddd(t), J = 7.0 Hz, 1H), 4.31–4.24 (m, 1H),
3.55 (d, J = 13.0 Hz, 2H), 3.51 (d, J = 13.0 Hz, 2H), 3.06–2.97
(m, 2H), 2.93 (dd, J = 7.5, 13.5 Hz, 1H), 2.73–2.67 (m, 1H), 2.26
(s, 12H), 1.34 (s, 9H); 13C NMR (CD3OD, 150 MHz) δ/ppm:
174.1 (s, 1C), 174.0 (s, 1C), 157.2 (s, 1C), 157.1 (s, 1C), 138.5 (s,
1C), 136.9 (s, 1C), 131.6 (d, 2C), 130.4 (d, 2C), 129.6 (d, 1C),
129.4 (d, 2C), 128.2 (d, 1C), 127.9 (d, 1C), 127.8 (s, 1C), 127.7
(d, 2C), 123.4 (s, 2C), 80.6 (s, 1C), 67.9 (t, 1C), 60.7 (t, 2C), 57.2
(d, 1C), 55.2 (d, 1C), 44.7 (q, 4C), 39.4 (t, 1C), 37.7 (t, 1C), 28.7
(q, 3C); HRMS (MALDI-TOF) m/z [M + H]+ calcd for
C36H48N4O6 633.3652, found 633.3623.
BOC-Asp(tBu)-Ala-1-OH (4)
To a solution of the activated Boc-Asp(tBu)-Ala-OSu (62.7 mg,
137.0 μmol) in CH3CN (500 μL), a solution of NaHCO3
(34.5 mg, 3.0 mmol, 10.0 eq.) and 1·HCl (37.7 mg, 137.0 μmol,
1.0 eq.) in CH3CN–H2O (1 : 2, 1.5 mL) was added. The reaction
mixture was stirred for 48 h at rt, before it was diluted with
H2O (2 mL) and the pH was adjusted to 4.0 with 1 M HCl. The
aqueous phase was extracted with EtOAc (3 × 15 mL). The com-
bined organic phases were washed with 1 M HCl (2 mL) and
brine (10 mL), dried over Na2SO4 and filtered. The solvent was
removed under reduced pressure to aﬀord the desired tri-
peptide 4 (54.5 mg 67%).
1H NMR (CD3CN, 500 MHz) δ/ppm: 7.23–7.22 (m, 1NH),
7.16 (s, 1H), 7.11 (d, J = 6.4 Hz, 1H), 7.02–7.00 (m, 1NH), 6.90
(d, J = 8.2 Hz, 1H), 5.90–5.89 (m, 1NH), 4.54 (q, J = 6.7 Hz, 1H),
4.34–4.33 (m, 1H), 4.27 (t, J = 7.0 Hz, 1H), 4.21 (s, 2H), 3.07
(dd, J = 5.3, 14.0 Hz, 1H), 2.95 (dd, J = 6.9, 14.0 Hz, 1H), 2.77
(s, 6H), 2.68 (dd, J = 5.4, 16.3 Hz, 1H), 2.54 (dd, J = 7.7, 16.3
Hz, 1H), 1.41 (s, 18H), 1.24 (d, J = 7.0 Hz, 3H); 13C NMR
(CD3CN, 126 MHz) δ/ppm: 173.0 (s, 1C), 172.9 (s, 1C), 172.3 (s,
Organic & Biomolecular Chemistry Paper
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1C), 171.1 (s, 1C), 155.9 (s, 1C), 134.2 (s, 1C), 133.5 (s, 1C),
129.4 (s, 1C), 129.3 (s, 1C), 117.4 (s, 1C), 116.8 (s, 1C), 82.0 (s,
1C), 80.6 (s, 1C), 57.3 (s, 1C), 54.6 (s, 1C), 52.4 (s, 1C), 49.9 (s,
1C), 43.4 (s, 2C), 38.2 (s, 1C), 36.6 (s, 1C), 28.5 (s, 3C), 28.2 (s,
3C), 18.1 (s, 1C); ESI-MS [M + H]+ calcd for C28H45N4O9
581.31811, found 581.31805.
General SPPS procedure
All peptides were synthesized using 2-CT resin via standard
Fmoc solid phase peptide synthesis with TBTU and DIPEA as
coupling reagents. Manual coupling of canonical amino acids
was performed for 40 min per coupling, with 2.5 equivalents
of Fmoc-amino acid and 4.0 equiv. of DIPEA and TBTU.
Tripeptide coupling to the resin was performed for 50 min,
with 1.0 equiv. of the tripeptide and 3.0 equiv. of DIPEA and
TBTU. Deprotection of the Fmoc-group was performed with a
20% piperidine solution in DMF for 2 × 15 min. The peptides
were deprotected and cleaved from the resin under acidic con-
ditions for 2 h [84%TFA/4% H2O/4% phenol/4% triisopropyl-
silane/4% 2,2′-(ethylenedioxy)diethanethiol]. The peptides
were then precipitated in cold Et2O, the supernatant was then
decanted and the precipitate was dried under reduced
pressure. The purification was achieved using reversed phase
HPLC on a 1260 Infinity system (Agilent Technologies) using a
C18 preparative column (21.2 × 250 mm, 10 μm, Agilent
Technologies) with gradients of System B (CH3CN, 0.1% TFA)
in System A (H2O, 0.1% TFA). The peptides were characterized
by electrospray ionization (ESI) mass spectrometry in positive
ion mode on an LTQ Orbitrap XL mass spectrometer. A Grace
Grom-Sil-120-ODS-4-HE (length 50 mm, ID 2 mm, 3 µm)
column was used employing a linear gradient of 20–100% over
10 minutes at 0.3 mL min−1. The solvent system used was A
(0.1% formic acid in H2O) and B (0.1% formic acid in CH3CN).
TC10b_3Y1
The peptide was prepared according to the general procedure
from 4 and 17-peptide intermediate bound to the resin. The
coupling conditions were: TBTU, DIPEA, DMF, 50 min. The
cleavage from the resin was achieved under acidic conditions.
ESI-MS: (M + H)+: 2144.06005.
m/z = 1072.53381 (M + 2H)2+, calcd for (M + 2H)2+:
1072.53366.
m/z = 715.35858 (M + 3H)3+, calcd for (M + 3H)3+:
715.35820.
m/z = 536.77075 (M + 4H)4+, calcd for (M + 4H)4+:
536.77047.
Irradiation experiments, general
A quartz vessel was filled with a solution of the tyrosine deriva-
tive or peptide (0.1 mmol) in CH3OH (50 or 100 mL). The solu-
tion was purged with Ar (30 min) and irradiated using a
Rayonet reactor at 300 nm with 11 lamps over 30–90 min
(1 lamp, 8 W). During irradiation, the solution was continu-
ously purged with Ar and cooled with a finger condenser. The
composition of the irradiated solution was analyzed by HPLC.
After the irradiation, the solvent was removed on a rotary evap-
orator and the residue was purified by chromatography.
Irradiation of 1B
Irradiation of 1B (54 mg, 0.12 mmol) in CH3OH (100 mL) for
40 min after purification by TLC using 10% CH3OH in CH2Cl2
as the eluent aﬀorded the pure product 6 (14 mg, 28%).
Colorless oil; 1H NMR (CD3OD, 300 MHz) δ/ppm: 7.38–7.26
(m, 6H), 6.86 (d, J = 8.4 Hz, 1H), 6.74 (d, J = 8.4 Hz, 1H), 6.68
(s, 1H), 5.17 (d, J = 12.6 Hz, 1H), 5.08 (d, J = 12.6 Hz, 1H), 4.96
(d, J = 7.6 Hz, 1H), 4.60–4.45 (m, 3H), 3.40 (s, 3H), 3.05–2.89
(m, 2H), 1.41 (s, 9H); 13C NMR (CD3OD, 150 MHz) δ/ppm:
171.8 (s, 1C), 155.5 (s, 1C), 155.1 (s, 1C), 135.3 (s, 1C), 130.3 (d,
1C), 128.9 (d, 2C), 128.6 (d, 1C), 128.5 (d, 2C), 127.9 (s, 1C),
127.0 (s, 1C), 122.0 (d, 1C), 116.6 (d, 1C), 79.9 (s, 1C), 74.0 (t,
1C), 67.0 (t, 1C), 58.2 (q, 1C), 54.6 (d, 1C), 37.4 (t, 1C), 28.7 (q,
3C); HRMS (MALDI-TOF) m/z [M]+ calcd for C23H29NO6
415.2073, found 415.2094.
Irradiation of 2B
Irradiation of 2B (62 mg, 0.11 mmol) in CH3OH (100 mL) for
30 min after purification by TLC using 10% CH3OH in CH2Cl2
as the eluent aﬀorded the pure product 7 (13 mg, 21%).
Colorless oil; 1H NMR (CD3OD, 600 MHz) δ/ppm: 7.38–7.33
(m, 3H), 7.30–7.24 (m, 5H), 7.24–7.18 (m, 1H), 7.17 (d, J = 7.0
Hz, 2H), 6.70–6.65 (m, 2H), 6.59 (s, 1H), 6.28 (br. s), 5.10 (d, J =
12.0 Hz, 1H), 5.07 (d, J = 12.0 Hz, 1H), 4.97 (br. s), 4.77–4.73
(m, 1H), 4.49 (d, J = 12.5 Hz, 1H), 4.46 (d, J = 12.5 Hz, 1H), 4.32
(br. s), 3.38 (s, 3H), 3.02 (d, J = 6 Hz, 2H), 2.94 (d, J = 6 Hz, 2H),
1.34 (s, 9H); 13C NMR (CD3OD, 150 MHz) δ/ppm: 170.8 (s),
170.7 (s), 155.2 (s), 136.5 (s), 135.0 (s), 130.2 (d), 129.4 (d),
129.0 (d), 128.7 (d), 128.6 (s), 128.54 (d), 128.51 (d), 126.9 (d),
126.6 (s), 122.1 (s), 116.5 (d), 80.2 (s), 73.8 (t), 67.1 (t), 58.2 (q),
55.7 (d), 53.4 (d), 38.3 (t), 37.0 (t), 28.2 (q), one singlet was not
seen; HRMS (MALDI-TOF) m/z [M + K]+ calcd for C32H38N2O7
601.2316, found 601.2328.
Irradiation of 3B
Irradiation of 3B (28 mg, 0.04 mmol) in CH3OH (50 mL) for
30 min after purification by TLC using 10% CH3OH in CH2Cl2
as the eluent aﬀorded the pure product 9 (5 mg, 21%).
Colorless oil; 1H NMR (CD3OD, 300 MHz) δ/ppm: 7.38–7.33
(m, 5H), 7.31–7.27 (m, 2H), 7.25–7.21 (m, 2H), 7.21–7.15 (m,
5H), 6.71 (s, 2H), 5.11–5.08 (s, 2H), 4.81–4.73 (m, 1H), 4.46 (s,
4H), 4.39–4.28 (m, 1H), 3.42–3.36 m, 6H), 3.13–2.88 (m, 4H),
1.37 (s, 9H); 13C NMR (CD3OD, 150 MHz) δ/ppm: 170.8 (s),
153.1 (s), 136.8 (s), 135.1 (s), 129.4 (d), 129.1 (d), 128.64 (d),
128.60 (d), 128.5 (d), 128.4 (d), 126.9 (d), 126.4 (s), 123.6 (s),
80.5 (s), 71.6 (t), 67.1 (t), 58.3 (q), 53.5 (d), 53.4 (d), 38.2 (t),
37.1 (t), 28.7 (q), two singlets were not seen; HRMS
(MALDI-TOF) m/z [M + K]+ calcd for C34H42N2O8 645.2578,
found 645.2570.
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Irradiation of 3A
Irradiation of 3A (59 mg, 0.11 mmol) in CH3OH (100 mL) for
75 min after purification by TLC using 10% CH3OH in CH2Cl2
as the eluent aﬀorded the pure product 10 (5 mg, 9%).
Colorless oil; 1H NMR (CD3OD, 300 MHz) δ/ppm: 7.30–7.15
(m, 5H), 7.04 (s, 2H), 6.94–6.84 (m, 1H), 4.68–4.57 (m, 1H),
4.54–4.50 (m, 4H), 4.31–4.24 (m, 1H), 3.38 (s, 6H), 3.19–2.98
(m, 2H), 2.76–2.63 (m, 2H), 1.33 (s, 9H); 13C NMR (CD3OD,
150 MHz) δ/ppm: 174.0 (s, 1C), 157.5 (s, 1C), 154.0 (s, 1C),
138.7 (s, 1C), 131.2 (d, 1C), 130.3 (d, 2C), 129.4 (d, 2C), 129.0
(s, 1C), 127.6 (d, 1C), 125.4 (s, 2C), 80.7 (s, 1C), 72.0 (t, 2C),
58.5 (q, 2C), 57.5 (d, 1C), 55.3 (d, 1C), 39.2 (t, 1C), 37.6 (t, 1C),
28.6 (q, 3C), one singlet was not seen; HRMS (MALDI-TOF) m/z
[M + K]+ calcd for C27H36N2O8 555.2109, found 555.2083.
Quantum yield of methanolysis
Quantum yields for photomethanolysis reactions were deter-
mined by using two actinometers simultaneously: KI/KIO3
(Φ254 = 0.74),
47,51 and photomethanolysis of 2-hydroxymethyl-
phenol (Φ254 = 0.23),
28 as recently described by us.71 The
measurement was performed in eight quartz cells of the same
dimensions that were irradiated from the front side only.
Solutions of tyrosines or peptide derivatives in CH3OH, and
actinometers were freshly prepared and their concentrations
were adjusted to have absorbances of 0.4–0.8 at 254 nm. After
adjustment of the concentrations and measurement of the
corresponding UV-vis spectra, the solutions were purged with
a stream of N2 (20 min), and then sealed with a cap. The cells
were placed in a holder which ensured an equal distance of all
samples from the lamp and were irradiated at the same time
in the reactor with 1 lamp at 254 nm for 1–15 min. Before and
after the irradiation, the samples were taken from the cells by
the use of a syringe and analyzed by HPLC to determine photo-
chemical conversions. The conversion did not exceed 30% to
avoid a change of the absorbance, or filtering of the light by
the product. From the conversion of actinometers irradiance
was calculated. Similar values were obtained for both actino-
meters. The mean value of two measurements was reported.
All equations for the calculation of quantum yields are given
in the ESI.†
Steady-state and time-resolved fluorescence measurements
The steady-state measurements were performed on a PTI
QM40 fluorometer at 20 °C. Excitation slits were set to a band-
pass of 3 nm, and emission slits to a bandpass of 2 nm. The
spectra were corrected for the fluctuations in lamp intensity
and transmission of optics. The samples were dissolved in
CH3CN, or CH3CN–H2O (1 : 1) and the concentrations were
adjusted to absorbances less than 0.1 at the excitation wave-
lengths of 250, 260 or 270 nm. Fluorescence quantum yields
were determined by comparison of the integral of the emission
bands with the one of anisole in cyclohexane (Φf = 0.29)
47
upon excitation at 260 nm. The quantum yields were calcu-
lated according to eqn (S1) in the ESI.† Fluorescence decays,
collected over 1023 time channels, were obtained on a single
photon counter using a light emitting diode for excitation at
260 nm. The instrument response functions, using LUDOX as
the scatterer, were recorded at the same wavelengths as the
excitation wavelength and had a half width of ≈0.2 ns.
Emission decays for samples in CH3CN solutions were
recorded at 310 nm. The counts in the peak channel were
1 × 103. The time increment per channel was 0.020 ns. The
obtained histograms were fit as sums of exponentials using
Gaussian-weighted non-linear least-squares fitting based on
Marquardt–Levenberg minimization implemented in the soft-
ware package from the instrument. The fitting parameters
(decay times and pre-exponential factors) were determined by
minimizing the reduced chi-square χ2 and graphical methods
were used to judge the quality of the fit that included plots of
the weighted residuals vs. channel number.
Laser flash photolysis (LFP)
All LFP studies were performed on a system at the University of
Victoria72 using as an excitation source a pulsed Nd:YAG laser
at 266 nm (<20 mJ per pulse), with a pulse width of 10 ns.
Static cells (7 mm × 7 mm) were used and the solutions were
purged with nitrogen or oxygen for 30 min prior to perform
the measurements. Absorbances at 266 nm were ∼0.3–0.5. For
the collection of decays on long time scales, a modification of
the setup was used, wherein the probing light beam from the
Xe-lamp was not pulsed.73
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